Literature DB >> 11872262

Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells.

Jie Bai1, Hajime Nakamura, Itaro Hattori, Masaki Tanito, Junji Yodoi.   

Abstract

Thioredoxin (TRX) is a redox-active protein which plays a cytoprotective role against oxidative stress. Geranylgeranylacetone (GGA), used widely as an anti-ulcer drug, has been reported to induce TRX as well as heat shock protein 70 (HSP70) in hepatocytes and other cells. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), causes dopaminergic denervation and Parkinsonism in humans. The 1-methyl-4-phenylpyridinium ion (MPP(+)), an active metabolite of MPTP, induces cell death in a rat pheochromocytoma cell line (PC12 cells). We found that MPP(+) suppresses TRX expression in PC12 cells. Overexpression or administration of TRX attenuates MPP(+)-induced neurotoxicity on PC12 cells. Moreover, GGA induces expression of TRX and HSP70 and attenuates MPP(+)-induced toxicity in PC12 cells. These results indicate that TRX and GGA have a possible potential as new therapeutic agents for Parkinson disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872262     DOI: 10.1016/s0304-3940(02)00058-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

Review 1.  Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease.

Authors:  Aracely Garcia-Garcia; Laura Zavala-Flores; Humberto Rodriguez-Rocha; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

Review 2.  Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

Authors:  Annadurai Anandhan; Maria S Jacome; Shulei Lei; Pablo Hernandez-Franco; Aglaia Pappa; Mihalis I Panayiotidis; Robert Powers; Rodrigo Franco
Journal:  Brain Res Bull       Date:  2017-03-21       Impact factor: 4.077

3.  Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt-Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress.

Authors:  Waqas Tahir; Saima Zafar; Franc Llorens; Amandeep Singh Arora; Katrin Thüne; Matthias Schmitz; Nadine Gotzmann; Niels Kruse; Brit Mollenhauer; Juan Maria Torres; Olivier Andréoletti; Isidre Ferrer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

4.  Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease.

Authors:  William M Johnson; Chen Yao; Sandra L Siedlak; Wenzhang Wang; Xiongwei Zhu; Guy A Caldwell; Amy L Wilson-Delfosse; John J Mieyal; Shu G Chen
Journal:  Hum Mol Genet       Date:  2014-10-29       Impact factor: 6.150

Review 5.  Application of recombinant thioredoxin1 for treatment of heart disease.

Authors:  Shouji Matsushima; Daniela Zablocki; Junichi Sadoshima
Journal:  J Mol Cell Cardiol       Date:  2010-10-16       Impact factor: 5.000

6.  DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway.

Authors:  Joo-Young Im; Kang-Woo Lee; Jong-Min Woo; Eunsung Junn; M Maral Mouradian
Journal:  Hum Mol Genet       Date:  2012-04-05       Impact factor: 6.150

7.  Nitrated alpha-synuclein and microglial neuroregulatory activities.

Authors:  Ashley D Reynolds; Irena Kadiu; Sanjay K Garg; Jason G Glanzer; Tara Nordgren; Pawel Ciborowski; Ruma Banerjee; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2008-01-17       Impact factor: 4.147

Review 8.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

Review 9.  Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection.

Authors:  Hiroshi Masutani; Jie Bai; Yong-Chul Kim; Junji Yodoi
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

Review 10.  Thioredoxin system regulation in the central nervous system: experimental models and clinical evidence.

Authors:  Daniela Silva-Adaya; María E Gonsebatt; Jorge Guevara
Journal:  Oxid Med Cell Longev       Date:  2014-02-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.